Project ECHO, which helps specialists disseminate knowledge to primary care providers, was created on the idea that patients should not be dying from curable diseases because they don’t have access to the right providers, said Sanjeev Arora, MD, FACG, MACP, director and founder of Project ECHO and a professor of medicine at University of New Mexico.
Project ECHO, which helps specialists disseminate knowledge to primary care providers, was created on the idea that patients should not be dying from curable diseases because they don’t have access to the right providers, said Sanjeev Arora, MD, FACG, MACP, director and founder of Project ECHO and a professor of medicine at University of New Mexico.
Transcript
As the founder of Project ECHO, can you explain when this program was started, what population it serves, and what inspired you to create it?
I’m a hepatitis C specialist and I was treating hepatitis C at the University of New Mexico in my clinic, and I recall a patient who she was a 43-year-old woman and she came to see me and there was an 8-month wait to see me in my clinic, and people were driving hundreds of miles to see me. Two hundred miles each way. And would have to make 12 to 18 trips to get treatment, because treatment involved weekly injections with interferon and another medicine that caused anemia, called ribavirin. When she saw me, she had 2 children—1 was a son, 14 years old, she had a daughter who was 9—and she wanted treatment for hepatitis C. She had been diagnosed with hepatitis C many years ago. Her husband had passed away in a car accident 5 years earlier, so she was a single mother.
And when I saw her, she had cancer of the liver already, which was the size of a baseball. And she really wanted to live because she had 2 children, but there was nothing we could do, and she died of a disease that is actually quite curable, because there were no doctors in her area that had the ability or knowledge to treat hepatitis C.
And over the years, I’ve had more than a hundred patients like that, who died of hepatitis C-related liver cancer when this was totally preventable, and because of the 8-month wait and the long drives, poor people couldn’t access me, and I thought I had to do something else to bring access to care to everyone in New Mexico who had this disease, so more people didn’t die of liver failure and liver cancers. And that’s how I started Project ECHO, to bring access to care for hepatitis C treatment to everyone, and then I knew if I could do that, I would have a model for complex diseases and rural locations and other countries.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More